济南龟头上出痒(济南几下就射了怎么咋办) (今日更新中)

BAIKONUR, Kazakhstan, April 5 (Xinhua) -- Russian manned spacecraft Soyuz TMA-21 has been transported to the launch pad and raised to a vertical position, ready to blast off on April 5, Xinhua correspondents reported Saturday from the site.The launch is dedicated to the 50th anniversary of the first flight into space in 1961 carried out by Russian cosmonaut Yuri Gagarin.For hours, journalists and tourists from all over the world had braved a nasty weather and watched the train and trucks delivering the rocket to the pad.Service towers move towards the Soyuz TMA-21 spacecraft, named after the first cosmonaut Yuri Gagarin, as it is set on its launch pad at Baikonur cosmodrome April 2, 2011. The International Space Station (ISS) crew of U.S. astronaut Ronald Garan and crew mates Russian cosmonauts Alexandr Samokutyaev and Andrey Borisenko is due to travel by Soyuz spacecraft to the ISS on April 5.The Soyuz TMA-21 rocket will deliver three crew members to the International Space Station (ISS) on April 5. In a six-month mission, these cosmonauts will carry out over 40 experiments.The Soyuz TMA modification is a replacement of the Soyuz TM as it was equipped with smaller and more efficient computers and improved displays. The Soyuz TMA-21 will also serve as the return vehicle of the ISS crew.

WELLINGTON, May 13 (Xinhua) -- While it's long been known that a little sunshine can spread happiness, researchers in New Zealand have found that it can also save the lives of pneumonia patients.Medical scientists have found that vitamin D, which is absorbed through the skin and produced with exposure to sunlight, is a major factor in the survival rate of pneumonia patients.Researchers at Waikato University collaborated with doctors at Waikato Hospital, both Hamilton-based institutions, to study blood samples of 112 patients admitted to the hospital with pneumonia during the winter.They found that those with severe vitamin D deficiency 17 of the patients were more likely to die within a month, compared with patients with normal or slightly low vitamin D levels.Dr Bob Hancox, of the hospital's department of respiratory medicine, said five of the 17 died, a 29-percent mortality rate, compared with four deaths among the 95 patients with higher vitamin D levels, a 4-percent mortality rate."The analysis confirmed that the difference in mortality rates between the two groups was very unlikely to be due to chance," Hancox told Xinhua.Vitamin D deficiency was a concern around the world, Hancox said."Sunlight is the main source of vitamin D, so it tends to be a winter problem in temperate climates when people spend a lot of time indoors. But it occurs in all countries and vitamin D deficiency is believed to be a major problem worldwide."There is accumulating evidence that we need vitamin D to help fight infections, such as pneumonia as we have shown, as well as improve bone health," he told Xinhua."What is not yet clear is whether we can do anything about it. We don't know whether treating people with vitamin D supplements would help to prevent or treat respiratory infections. This is what we need to find out now."Dr Ray Cursons, of the Biological Sciences department at Waikato University, said patient age, sex, additional health conditions, and other prognostic factors did not affect the research outcome, although researchers still could not establish a causal link between vitamin D deficiency and mortality in the patients.Waikato Hospital D respiratory specialist Dr Noel Karalus said it was not yet known whether giving patients vitamin D supplements after their admission to hospital with respiratory tract infections would alter outcomes."It may transpire that vitamin D helps us avoid infection rather than cure it once established."Cursons said the best source of vitamin D was sunlight as dietary sources such as fatty fish and cod liver oil did not contain enough vitamin D."There is still some controversy regarding the optimal daily allowance of vitamin D. How much we absorb through the skin depends on sun exposure, skin type and geographical latitude. M ori and Pacific Islanders absorb less because of their darker skin, and people in colder climates also have lower levels of vitamin D. "Pneumonia is the single largest cause of death in children worldwide, killing an estimated 1.6 million children under the age of five each year, according to the World Health Organization.The research findings are published in the journal Respirology, published by the Asian Pacific Society of Respirology, this month.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

LOS ANGELES, May 20(Xinhua)-- Peter, a Chinese American who works for the post office in Rosemead, California, said he has been attacked by dogs twice in the past 10 years while delivering mails.He said as a mail carrier, he has to walk door to door to put mails into the mailboxes of the residents, and many times the owners were not at home but their dogs were too loyal to their duties and would see mail carriers like him as intruders."It is dangerous to be a mail carrier. The enemy is not humans but animals like dogs who have been generally seen as human's best friends," Peter, who asked not to identify his full name, told Xinhua.Mail carriers in the United States feel the real danger of being attacked by dogs while delivering mails door by door.Statistics released by the U.S. Post Office showed that 5,669 postal employees were attacked by dogs in 2010 in the United States. That's an average of 11 dog attacks every delivery day, and that figure does not include the number of threatening incidents that did not result in injury.Los Angeles is the third most dangerous city in the U.S. when it comes to being a mail carrier with 44 mail carriers being attacked by dogs in 2010, according to the U.S. Post Office.San Diego in California and Columbus in Ohio tied for second place, each logging 45 dog attacks. Houston in Texas is the most dangerous city in the U.S. for mail carriers with 62 attacks in 2010.On May 25, 2010, Eddie Lin, a 33-year old Chinese American postal carrier in San Diego, was attacked by a dog while delivering mail, his head hit on the ground and died 10 days later. His death angered his family and the whole community.The daughter of the dog's owner, who identified herself as Eva, said the incident has devastated her father."We feel really bad," Eva told the local press in an interview. "It's just killing my Dad," she added.On Sept. 30, 2010, a German Shepard and a Pitbull mix attacked Hu Ruiz, a 10-year veteran of the U.S. Postal Service. He luckily recovered from puncture wounds on his arms after the two dogs attacked him as he made deliveries along Camden Avenue in San Jose, California.It is not the problem for the mail carriers only. Dogs attack other people too. Statistics showed that there are more than 4.7 million Americans bitten by dogs nationwide annually.

WELLINGTON, May 13 (Xinhua) -- While it's long been known that a little sunshine can spread happiness, researchers in New Zealand have found that it can also save the lives of pneumonia patients.Medical scientists have found that vitamin D, which is absorbed through the skin and produced with exposure to sunlight, is a major factor in the survival rate of pneumonia patients.Researchers at Waikato University collaborated with doctors at Waikato Hospital, both Hamilton-based institutions, to study blood samples of 112 patients admitted to the hospital with pneumonia during the winter.They found that those with severe vitamin D deficiency 17 of the patients were more likely to die within a month, compared with patients with normal or slightly low vitamin D levels.Dr Bob Hancox, of the hospital's department of respiratory medicine, said five of the 17 died, a 29-percent mortality rate, compared with four deaths among the 95 patients with higher vitamin D levels, a 4-percent mortality rate."The analysis confirmed that the difference in mortality rates between the two groups was very unlikely to be due to chance," Hancox told Xinhua.Vitamin D deficiency was a concern around the world, Hancox said."Sunlight is the main source of vitamin D, so it tends to be a winter problem in temperate climates when people spend a lot of time indoors. But it occurs in all countries and vitamin D deficiency is believed to be a major problem worldwide."There is accumulating evidence that we need vitamin D to help fight infections, such as pneumonia as we have shown, as well as improve bone health," he told Xinhua."What is not yet clear is whether we can do anything about it. We don't know whether treating people with vitamin D supplements would help to prevent or treat respiratory infections. This is what we need to find out now."Dr Ray Cursons, of the Biological Sciences department at Waikato University, said patient age, sex, additional health conditions, and other prognostic factors did not affect the research outcome, although researchers still could not establish a causal link between vitamin D deficiency and mortality in the patients.Waikato Hospital D respiratory specialist Dr Noel Karalus said it was not yet known whether giving patients vitamin D supplements after their admission to hospital with respiratory tract infections would alter outcomes."It may transpire that vitamin D helps us avoid infection rather than cure it once established."Cursons said the best source of vitamin D was sunlight as dietary sources such as fatty fish and cod liver oil did not contain enough vitamin D."There is still some controversy regarding the optimal daily allowance of vitamin D. How much we absorb through the skin depends on sun exposure, skin type and geographical latitude. M ori and Pacific Islanders absorb less because of their darker skin, and people in colder climates also have lower levels of vitamin D. "Pneumonia is the single largest cause of death in children worldwide, killing an estimated 1.6 million children under the age of five each year, according to the World Health Organization.The research findings are published in the journal Respirology, published by the Asian Pacific Society of Respirology, this month.

来源：资阳报